A series of monthly, hour-long webinars for IDSA members on
current recommended practices to effectively identify, treat, and manage
patients infected with the hepatitis C virus.
Up-to-date guidance for the
treatment of HCV infection from IDSA and the American Association for the Study
of Liver Diseases, in collaboration with the International Antiviral
IDSA offers a Maintenance of Certification
module specific to Hepatitis C.
Viral hepatitis is a silent epidemic. According to the United States Department of Health and Human Services, it is estimated that 2.7 to 3.9 million persons are infected with the hepatitis C virus (HCV) in the United States alone. An enormous public health danger lies in the fact that many infected patients are unaware of their diseased state. HCV's slow disease progression can lead to liver cirrhosis or hepatocellular carcinoma, which ultimately requires transplantation or causes mortality.
Up-to-date guidance for the treatment of HCV infection from IDSA and the AASLD. >> Go to HCVguidelines.org
The U.S. Preventive Services Task Force (USPSTF) recommends screening for HCV infection to adults born between 1945-1965. Read the full report >>
State-by-state information for hepatitis C patients >>
| IDSA | Contact Us
© Copyright HIVMA 2017 HIV Medicine Association